Non Small Cell Lung Cancer

Showing 1 - 25 of 622

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial (IMT-009)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +11 more
  • (no location specified)
Sep 29, 2022

Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)

Not yet recruiting
  • Cervical Cancer
  • +13 more
  • (no location specified)
Sep 28, 2022

Lung Cancer, Non Small Cell Lung Cancer, Circulating Tumor Cell Trial (Endobronchial ultrasound)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • Endobronchial ultrasound
  • (no location specified)
Sep 27, 2022

Non Small Cell Lung Cancer Trial in Beijing (DZD9008)

Recruiting
  • Non Small Cell Lung Cancer
  • Beijing, Beijing, China
    Department of Respiratory and Critical Care Medicine, Peking Uni
Sep 24, 2022

I3LUNG: Integrative Science, Intelligent Data Platform for

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
    • Chicago, Illinois
    • +3 more
    Sep 13, 2022

    Lung Cancer, Non Small Cell Lung Cancer, Adenocarcinoma of Lung Trial run by the National Cancer Institute (NCI) (LMB-100,

    Recruiting
    • Lung Cancer
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Puerto Rico, United States (HBI-2376)

    Recruiting
    • Non Small Cell Lung Cancer
    • +6 more
    • Duarte, California
    • +11 more
    Aug 23, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (Telisotuzumab Vedotin)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Telisotuzumab Vedotin
    • Clayton, Victoria, Australia
    • +54 more
    Aug 23, 2022

    Non Small Cell Lung Cancer Trial in United States (HBI-8000 in combination with pembrolizumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • HBI-8000 in combination with pembrolizumab
    • Goodyear, Arizona
    • +5 more
    Aug 18, 2022

    Non Small Cell Lung Cancer Trial in Tianjin (Osimertinib, Bevacizumab Biosimilar IBI305, Carboplatin)

    Recruiting
    • Non Small Cell Lung Cancer
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Aug 18, 2022

    Advanced Solid Cancer, Non Small Cell Lung Cancer, Esophageal Cancer Trial in China (APG-2449)

    Recruiting
    • Advanced Solid Cancer
    • +4 more
    • Beijing, Beijing, China
    • +9 more
    Aug 17, 2022

    Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

    Recruiting
    • Mesothelioma
    • +14 more
    • Los Angeles, California
    • +13 more
    Aug 16, 2022

    Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

    Available
    • Non Small Cell Lung Cancer
    • +6 more
    • Goodyear, Arizona
    • +67 more
    Aug 17, 2022

    Non Small Cell Lung Cancer Trial in Beijing (Ensartinib)

    Recruiting
    • Non Small Cell Lung Cancer
    • Beijing, Beijing, China
    • +1 more
    Aug 17, 2022

    Investigate Rectal Mucus in Aero-Digestive Tract Cancer.

    Recruiting
    • Non Small Cell Lung Cancer
    • +4 more
    • Oricol Test
    • Exeter, United Kingdom
      Royal Devon & Exeter NHS Foundation Trust
    Aug 15, 2022

    Solid Tumor, Adult, Metastatic Solid Tumor, Metastatic NSCLC Trial in Adelaide (BBP-398, sotorasib)

    Recruiting
    • Solid Tumor, Adult
    • +3 more
    • Adelaide, South Australia, Australia
      Cancer Research SA
    Aug 15, 2022

    Non Small Cell Lung Cancer, KRAS Activating Mutation, Advanced Cancer Trial in United States (VS-6766 and adagrasib)

    Recruiting
    • Non Small Cell Lung Cancer
    • +5 more
    • VS-6766 and adagrasib
    • Aurora, Colorado
    • +3 more
    Aug 12, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (Telisotuzumab Vedotin, Docetaxel)

    Recruiting
    • Non Small Cell Lung Cancer
    • Los Angeles, California
    • +209 more
    Aug 12, 2022

    Locally Advanced and Metastatic Non-Small Cell Lung Cancer

    Recruiting
    • Non Small Cell Lung Cancer
    • Abbeville Cedex, France
    • +52 more
    Aug 11, 2022

    Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)

    Recruiting
    • Advanced Solid Tumor
    • +18 more
    • PT199
    • Anti-PD-1 monoclonal antibody
    • Huntersville, North Carolina
    • +2 more
    Aug 10, 2022

    Non Small Cell Lung Cancer, ALK Gene Mutation Trial in France (Brigatinib 180 MG, Carboplatin, Pemetrexed)

    Recruiting
    • Non Small Cell Lung Cancer
    • ALK Gene Mutation
    • Brigatinib 180 MG
    • +2 more
    • Angers, France
    • +31 more
    Aug 9, 2022

    Non Small Cell Lung Cancer, Non-small Cell Carcinoma, NSCLC Trial in Saint Louis (Zimberelimab, Domvanalimab, Etrumadenant)

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Aug 8, 2022

    Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

    Recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • Core needle biopsy
    • Madison, Wisconsin
      Elephas
    Aug 4, 2022

    Lung Cancer, Lung Cancer Metastatic, Brain Metastases Trial in Sacramento ([18F]-avß6-BP)

    Recruiting
    • Lung Cancer
    • +3 more
    • Sacramento, California
      The University of California Davis Comprehensive Cancer Center
    Aug 3, 2022